TARDBP and amyotrophic lateral sclerosis: To the best of our knowledge, the present work is the first to investigate the deregulation of circulating miRNAs in ALS familiar forms with incomplete penetrance, focusing on a rare TARDBP mutation in addition to supplying a serum miRNA signature that may contribute to the assessment of preclinical progression for ALS.